-
Mashup Score: 14
SOFT TISSUE & BONE SARCOMA GROUP
Source: www.eortcresearchfund.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1EORTC SPRINT clinical cancer trial receives support from Rising Tide Foundation to reduce the burden for patients - 18 day(s) ago
Rising Tide Foundation for Clinical Cancer Research (RTFCCR) has awarded a grant to the EORTC 2387-SPRINT academic clinical study, the…
Source: www.eortcresearchfund.orgCategories: General Medicine News, Oncologists1Tweet-
🙏Grateful to the Rising Tide Foundation for supporting the EORTC 2387-SPRINT study, the first pan-European Trial within Cohorts targeting patients with oligometastatic disease from primary breast, prostate, lung, and colorectal cancers. 👉https://t.co/n12iZWdzl6 #Oncology https://t.co/KTPOw4UO11
-
-
Mashup Score: 11Soft Tissue & Bone Sarcoma Group - EORTC Cancer Research Fund - 1 year(s) ago
SOFT TISSUE & BONE SARCOMA GROUP
Source: www.eortcresearchfund.orgCategories: General Medicine News, Onc News and JournalsTweet-
❗Today Dr. @WinanvanHoudt will present #STRASS2, a randomized phase III study of neoadjuvant #chemotherapy followed by surgery versus surgery alone for patients with high-risk #RetroperitonealSarcoma, at the 2023 @ctosociety annual meeting. Learn more: https://t.co/qJSdg4Ae5T https://t.co/CWce95IvCc
-
❗Today Dr. @WinanvanHoudt will present #STRASS2, a randomized phase III study of neoadjuvant #chemotherapy followed by surgery versus surgery alone for patients with high-risk #RetroperitonealSarcoma, at the 2023 @ctosociety annual meeting. Learn more: https://t.co/qJSdg4Ae5T https://t.co/CWce95IvCc